Arcutis Biotherapeutics, Inc. financial data

Symbol
ARQT on Nasdaq
Location
3027 Townsgate Road, Suite 300, Westlake Village, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 357 % -31.5%
Quick Ratio 18.6 % +8.84%
Debt-to-equity 137 % -13.8%
Return On Equity -29.7 % +75.1%
Return On Assets -12.5 % +72.8%
Operating Margin -12 % +90.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 122M shares +4.65%
Common Stock, Shares, Outstanding 120M shares +2.81%
Entity Public Float 984M USD +102%
Common Stock, Value, Issued 12K USD 0%
Weighted Average Number of Shares Outstanding, Basic 128M shares +2.67%
Weighted Average Number of Shares Outstanding, Diluted 133M shares +6.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 318M USD +129%
Research and Development Expense 71.1M USD -17.1%
Costs and Expenses 356M USD +11.1%
Operating Income (Loss) -38.2M USD +79%
Nonoperating Income (Expense) -14.6M USD -354%
Income Tax Expense (Benefit) 1.02M USD +147%
Net Income (Loss) Attributable to Parent -44.3M USD +77.3%
Earnings Per Share, Basic 0 USD/shares +78.2%
Earnings Per Share, Diluted 0 USD/shares +78.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 47.1M USD -65.1%
Accounts Receivable, after Allowance for Credit Loss, Current 115M USD +91.5%
Inventory, Net 22.4M USD +60%
Assets, Current 349M USD -17.6%
Property, Plant and Equipment, Net 1.22M USD +2.45%
Operating Lease, Right-of-Use Asset 4.57M USD +122%
Intangible Assets, Net (Excluding Goodwill) 15.4M USD +57%
Other Assets, Noncurrent 596K USD 0%
Assets 371M USD -15.2%
Accounts Payable, Current 5.8M USD -70%
Employee-related Liabilities, Current 18.3M USD +17.1%
Accrued Liabilities, Current 93M USD +76.1%
Liabilities, Current 99.8M USD -42.1%
Operating Lease, Liability, Noncurrent 5.28M USD +90.3%
Other Liabilities, Noncurrent 360K USD -14.3%
Liabilities 213M USD -24.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -62K USD -112%
Retained Earnings (Accumulated Deficit) -1.16B USD -3.99%
Stockholders' Equity Attributable to Parent 158M USD +0.91%
Liabilities and Equity 371M USD -15.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -30.4M USD +3.87%
Net Cash Provided by (Used in) Financing Activities 395K USD -99.8%
Net Cash Provided by (Used in) Investing Activities 11.8M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 120M shares +2.81%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -18.2M USD -118%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 47.4M USD -65%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.57M USD -60.6%
Deferred Tax Assets, Valuation Allowance 256M USD +18.6%
Deferred Tax Assets, Gross 257M USD +18.5%
Operating Lease, Liability 3.38M USD -17.9%
Depreciation 153K USD -10%
Payments to Acquire Property, Plant, and Equipment 608K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -44.9M USD +76.9%
Lessee, Operating Lease, Liability, to be Paid 3.82M USD -20.7%
Property, Plant and Equipment, Gross 3.61M USD +4.1%
Operating Lease, Liability, Current 842K USD +11.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.05M USD +2.93%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.02M USD +3.02%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 436K USD -37.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.09M USD +3.13%
Deferred Tax Assets, Operating Loss Carryforwards 172M USD +12.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 42.3M USD +2.17%
Lessee, Operating Lease, Liability, to be Paid, Year Four 653K USD -39.9%
Operating Lease, Payments 241K USD +36.9%
Additional Paid in Capital 1.31B USD +3.66%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 2.98M USD +1485%
Share-based Payment Arrangement, Expense 39.2M USD -5.57%
Interest Expense 30.2M USD +44.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%